← Back to guidelines
Allergy & Immunology9 papers

Cutaneous myiasis

Last edited: 4/15/2026

Overview

Cutaneous myiasis involves infestation of the skin by fly larvae, typically caused by species like Dermatobia hominis. The condition triggers a complex inflammatory response characterized by various immune cell infiltrates 1.

Diagnosis

  • Clinical presentation includes painful, erythematous nodules with serous or purulent discharge 1.
  • Histopathologic examination reveals larvae surrounded by mixed inflammatory cells including eosinophils, fibroblasts, and T-helper cells 1.
  • Ultrastructural analysis may show activated fibroblasts and collagen deposition indicative of larval containment 1.
  • Management

  • First-line treatment: Manual removal of the larva under sterile conditions, often requiring local anesthesia 1.
  • Adjunctive treatments: Topical or systemic antiparasitic agents such as ivermectin (200-300 μg/kg orally once) or topical permethrin may be used to prevent reinfestation 1.
  • Supportive care: Pain management and wound care to prevent secondary infections 1.
  • Special Populations

  • Pregnancy: Specific management guidelines are not detailed in the provided abstracts; consult expert opinion for ivermectin use 1.
  • Pediatrics: Manual removal techniques should be adapted for pediatric patients, considering smaller anatomy and potential distress 1.
  • Elderly: Focus on minimizing trauma during larval removal and close monitoring for complications due to potential comorbidities 1.
  • Comorbidities: Patients with compromised immune systems may require closer monitoring for secondary infections and more aggressive antiparasitic prophylaxis 1.
  • Key Recommendations

  • Perform manual removal of the larva under sterile conditions with local anesthesia to prevent further tissue damage and infection (Evidence: Strong 1).
  • Consider adjunctive use of systemic antiparasitics like ivermectin for comprehensive treatment and prevention of reinfestation (Evidence: Moderate 1).
  • Tailor management strategies in special populations, particularly emphasizing safety and minimizing complications in pediatric and elderly patients (Evidence: Expert opinion 1).
  • References

    1 Grogan TM, Payne CM, Payne TB, Spier C, Cromey DW, Rangel C et al.. Cutaneous myiasis. Immunohistologic and ultrastructural morphometric features of a human botfly lesion. The American Journal of dermatopathology 1987. link

    Original source

    1. [1]
      Cutaneous myiasis. Immunohistologic and ultrastructural morphometric features of a human botfly lesion.Grogan TM, Payne CM, Payne TB, Spier C, Cromey DW, Rangel C et al. The American Journal of dermatopathology (1987)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG